Efficacy and Safety of Docetaxel Plus Oxaliplatin and Capecitabine in the First Line Treatment of Advanced Gastric Adenocarcinoma

Objective. To evaluate the efficacy and safety of docetaxel plus oxaliplatin and capecitabine (DOX) in the first line treatment of advanced gastric adenocarcinoma. Methods. A total of 37 patients were enrolled into this study, and they received DOX regimen (docetaxel 75 mg/m(2) and oxaliplatin 130 m...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Liu, Ying, Ye, Zhengbao, Xi, Wenqi, Ma, Tao, Shi, Min, Yang, Liu, Zhu, Zhenggang, Zhang, Jun
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi Publishing Corporation 2013
Предметы:
Clinical Study
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3787590/
https://ncbi.nlm.nih.gov/pubmed/24151630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/971096
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы